Other

Government Blockchain Association (GBA) Releases Voting Solution Assessment Model

  Washington, DC, September 19 — The Government Blockchain Association (GBA) announces the release of the Blockchain Maturity Model (BMM) Voting Supplement. "The Voting Supplement is a critical resource for governments, organizations, and developers worldwide, providing a comprehensive framework to ensure the privacy, security, and integrity of voting systems," said Susan Eustis, Chair of the GBA Voting Working Group. "Its scope extends beyond government elections, making it applicable businesses, associations and other forms of governance, enhancing trust in democratic outcomes." The supplement is a roadmap for developers and administrators seeking

Cardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases

  In the United States, heart disease accounts for a significant number of deaths every year, with cardiovascular disease being the primary concern. Factors like lifestyle choices and unforeseen circumstances contribute to its prevalence. Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the heart's lining) are two inflammatory heart conditions primarily linked to immunological reactions from viral infections and mRNA vaccines. Though considered rare, awareness of these conditions is growing, especially among younger populations. Recent research in Science Immunology highlighted an increase in cytokine production leading to myocarditis

Zumo first to launch platform built to meet the tech requirements of the FCA’s new Financial Promotions Regime for Crypto Assets

  The award-winning platform has set a new benchmark in consumer protection and regulatory alignment With some UK operators having to pause activity, Zumo’s financial promotions technical flow is now also available through its B2B API to support unregistered firms with remaining compliant after the 8 October deadline [London/Edinburgh - Friday 29 September 2023] Zumo, the UK-based digital-asset-as-a-service platform, has announced a significant industry milestone as it becomes the first digital asset platform to have integrated tech based requirements of the Financial Conduct Authority’s (FCA’s) new financial promotions regime for

HealthCare AI: The Unavoidable Revolution in Modern Medicine

By Eric Greenberg www.linkedin.com/in/ericabg In the evolving landscape of medical technology, there's one force that stands head and shoulders above the rest, promising a seismic shift in the very ethos of healthcare delivery: Artificial Intelligence (AI). As a seasoned technology and banking analyst, it is my considered opinion that Healthcare AI isn't just a trend or a buzzword. It’s the very future of medicine, poised to reshape everything we know about patient care, disease diagnosis, and medical research. To begin with, the economic implications of integrating AI in healthcare are

The Tightrope of Regulation

In a significant move at the recent G20 meeting in India, the International Monetary Fund (IMF) and the Financial Stability Board (FSB) released a joint paper outlining a framework for the global regulation of cryptocurrencies. While the proposals mostly tread familiar territory, what’s new is their conviction in crypto’s unstoppable growth and success. A flurry of optimism greeted the G20’s endorsement of the report because it advocates that countries don’t ban crypto. Hidden in its text, however, are some worrying signs. For example, on the first page, they state, “Widespread

REED AUTISM SERVICES AND NEWHD MEDIA FORGE INNOVATIVE PARTNERSHIP TO EMPOWER INDIVIDUALS WITH AUTISM IN BROADCASTING

[gallery columns="2" size="medium" link="none" ids="2892134,2892135"] [Franklin Lakes, NJ] – REED Autism Services, a leading non-profit organization providing programs and services to individuals with autism throughout their lifetime, has joined forces with NEWHD Media, a unique media platform that provides jobs for people with autism spectrum disorder (ASD), to create transformative opportunities in the field of broadcasting. Studies show that nearly half of all 25-year-olds with autism have never held a paying job. REED and NEWHD Media are working together to break down barriers and offer avenues for personal and professional

ESG1 Partners with GMEX ZERO13 on Trading Tokenized Carbon Credits from Emissions Removals

Cross-chain interoperable ESG asset trading and settlement enabled by ZERO13 as a fully integrated market distribution partner for ESG1’s highly verified, IoT-linked industrial carbon credit tokens. London and Calgary, 14 September 2023: ZERO13, a GMEX Group initiative providing a digital climate fintech aggregation ecosystem, and ESG1, a subsidiary of GuildOne providing innovative digital assets and ESG solutions built on R3’s Corda, have announced a landmark collaboration that will create an automated digital pipeline for North American industrial carbon offsets to reach high-demand markets in Europe and the Middle East. ESG1’s

Welcome Renal Warriors

I am a 68 year old man born in Brooklyn, New York and living for decades in Ithaca, NY. I also have 10 years each with homes in @San Ramon, Costa Rica and @Austin, Texas. My present and future dreams are in #Africa and I am setting up a base in @CapeTown, South Africa. #notmytimetodie #supportmymiracle #childofimmigrants #latebloomer. I was told a year ago that I would certainly die if I did not have not follow the standard treatment of care. I rejected both dialysis and a transplant and am

Blockpass integrates award-winning ID system with Solana Wallets, offers special discount to Solana projects

HONG KONG, Sept 7, 2023 - (ACN Newswire) - Blockpass has announced that it will be integrating its identity verification solution with Solana Wallets and supporting Solana projects with its revolutionary On-Chain KYC(R) solution. Additionally, Blockpass will provide a unique special offer available to all Solana projects in the form of a 50% discount. Solana is a blockchain network with the fundamental ideals of an open-source community, decentralization, staking and censorship resistance at its heart. The Solana network is validated by thousands of independently-operating nodes that ensures data remains secure

Starbox Group’s StarboxAI – ViPro Module: Transforming Content Creation

Kuala Lumpur, Malaysia, Sept 5th, 2023 – Starbox Group Holdings Ltd. (Nasdaq: STBX), a dynamic player in cash rebates, digital advertising, and payment solutions, with a vision of leading in artificial intelligence (“AI”) solutions throughout Southeast Asia, is making waves with the launch of its groundbreaking StarboxAI - ViPro module. This innovative module introduces a text-to-video feature set to redefine content creation. The Text-to-Video feature within the StarboxAI - ViPro module is not just an addition; it's a revelation. It empowers content creators to seamlessly transmute textual instructions or scripts

Starbox Group Holdings Ltd. Announces First Half of Fiscal Year 2023 Financial Results

Revenue and Net Profit Increased with Technology Driven Services Revenue Accounted for Approximately 43.8% of its Revenue KUALA LUMPUR, Malaysia, August 29, 2023 / Plato / Amplifi. Starbox Group Holdings Ltd. (Nasdaq: STBX) ("Starbox" or "the Company”), a service provider of cash rebates, digital advertising, and payment solutions with a goal of becoming a comprehensive AI solutions provider within Southeast Asia, today announced its unaudited financial results for the six months ended March 31, 2023. Mr. Lee Choon Wooi, Chairman and Chief Executive Officer of Starbox, commented, “We are excited

Gain Therapeutics Achieves Remarkable Breakthrough in Parkinson’s Disease Research

Gain Therapeutics, Inc. (Nasdaq: GANX), a pioneering biotechnology company specializing in innovative allosteric small molecule therapies, has made significant strides in the fight against Parkinson's disease (PD). The Company's lead drug candidate, GT-02287, has demonstrated extraordinary potential in mitigating the effects of Parkinson's disease across two distinct preclinical models of the ailment. These findings suggest that GT-02287 has the capacity to alleviate Parkinson's disease pathology and enhance motor function. A notable highlight is the substantial reduction of plasma Neurofilament Light Chain (NfL) levels, an emerging biomarker for neurodegeneration. This advancement